Hepatitis B reactivation in patients receiving immunosuppressive therapy: a hidden menace
HEPATOLOGY INTERNATIONAL (2017)
Journal
HEPATOLOGY INTERNATIONAL
Volume 11, Issue 1, Pages 31-33Publisher
SPRINGER
Keywords
Categories
Ask authors/readers for more resources
Authors
I am an author on this paper
Reviews
Recommended
Resolved hepatitis B infection in patients receiving immunosuppressive therapy: Monitor versus prophylaxis against viral reactivation
Mohamed A. Elsebaey, Tamer A. Elbedewy, Heba Elashry, Waleed Elrefaey, Samah A. Elshweikh, Ahmed A. Elhadidy, Neveen A. Shalaby, Assem Mohamed Elsokkary, Hossam Eldin A. Elashtokhy, Yousry Esam-Eldin Abo-Amer, Ashraf Rafat Abo-Elfetoh, Sharaf Elsayed Ali Hassanien, Amina Fouad, Raghda Samir Abdellatif, Amro Abdelaziz Mohammed Ismail
MEDICINE (2022)
Prevention of Hepatitis B Reactivation in Patients Receiving Immunosuppressive Therapy: a Case Series and Appraisal of Society Guidelines
Samuel Etienne, Jurg Vosbeck, Christine Bernsmeier, Michael Osthoff
JOURNAL OF GENERAL INTERNAL MEDICINE (2023)
Effect of an Electronic Alert System on Hepatitis B Virus Reactivation in Patients Receiving Immunosuppressive Drug Therapy
Akira Asai, Saho Hirai, Keisuke Yokohama, Tomohiro Nishikawa, Hiroki Nishikawa, Kazuhide Higuchi
JOURNAL OF CLINICAL MEDICINE (2022)
Management of Hepatitis B Virus Reactivation in Malignant Lymphoma Prior to Immunosuppressive Treatment
Yu-Fen Tsai, Chin-Mu Hsu, Hui-Hua Hsiao
JOURNAL OF PERSONALIZED MEDICINE (2021)
Meta-analysis: hepatitis B reactivation in patients receiving biological therapy
Haidar Aljamali, Guy D. Eslick, Martin Weltman
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2022)
APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy
George Lau, Ming-Lung Yu, Grace Wong, Alexander Thompson, Hasmik Ghazinian, Jin-Lin Hou, Teerha Piratvisuth, Ji-Dong Jia, Masashi Mizokami, Gregory Cheng, Guo-Feng Chen, Zhen-Wen Liu, Oidov Baatarkhuu, Ann Lii Cheng, Woon Leung Ng, Patrick Lau, Tony Mok, Jer-Ming Chang, Saeed Hamid, A. Kadir Dokmeci, Rino A. Gani, Diana A. Payawal, Pierce Chow, Joong-Won Park, Simone Strasser, Rosmawaiti Mohamed, Khin Maung Win, Tanwandee Tawesak, Shiv Kumar Sarin, Masao Omata
HEPATOLOGY INTERNATIONAL (2021)
Hepatitis B virus and hepatitis C virus reactivation in cancer patients receiving novel anticancer therapies
Khalis Mustafayev, Harrys Torres
CLINICAL MICROBIOLOGY AND INFECTION (2022)
Risk of hepatitis B reactivation in patients receiving anti-tumor necrosis factor-α therapy
Sami Fidan, Erhan Capkin, Deniz Aksu Arica, Serdar Durak, Ilyas Ercan Okatan
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2021)
Reactivation of Hepatitis B Virus in Lung Cancer Patients Receiving Tyrosine Kinase Inhibitor Treatment
Po-Hsin Lee, Yen-Hsiang Huang, Yu-Wei Hsu, Kun-Chieh Chen, Kuo-Hsuan Hsu, Ho Lin, Teng-Yu Lee, Jeng-Sen Tseng, Gee-Chen Chang, Tsung-Ying Yang
JOURNAL OF CLINICAL MEDICINE (2023)
Hepatitis B virus reactivation in seronegative occult hepatitis B patient receiving ibrutinib therapy
Lok-Ka Lam, Thomas Sau Yan Chan, Yu-Yan Hwang, Lung-Yi Mak, Wai-Kay Seto, Yok-Lam Kwong, Man-Fung Yuen
VIROLOGY JOURNAL (2023)
Prevention of hepatitis B reactivation in patients requiring chemotherapy and immunosuppressive therapy
Chih-An Shih, Wen-Chi Chen
WORLD JOURNAL OF CLINICAL CASES (2021)
Hepatitis B reactivation in cancer patients receiving immune checkpoint inhibitors: a systematic review and meta-analysis
Zhengzheng Xia, Jianyu Zhang, Wenjun Chen, Haiyan Zhou, Di Du, Kongcai Zhu, Hui Chen, Jun Meng, Jun Yang
INFECTIOUS DISEASES OF POVERTY (2023)
HBsAg (-)/HBsAb (-)/HBeAg (-)/HBeAb (+)/HBcAb (+) predicts a high risk of hepatitis B reactivation in patients with B-cell lymphoma receiving rituximab based immunochemotherapy
Li-Ping Shui, Yan Zhu, Xiao-Qin Duan, Yu-Ting Chen, Li Yang, Xiao-Qiong Tang, Hong-Bin Zhang, Qing Xiao, Li Wang, Lin Liu, Xiao-Hua Luo
JOURNAL OF MEDICAL VIROLOGY (2023)
High Risk of Viral Reactivation in Hepatitis B Patients with Systemic Lupus Erythematosus
Ming-Han Chen, Chien-Sheng Wu, Ming-Huang Chen, Chang-Youh Tsai, Fa-Yauh Lee, Yi-Hsiang Huang
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Risk factors associated with cytomegalovirus reactivation in patients receiving immunosuppressive therapy for rheumatic diseases: a retrospective study
Tatsuya Shimada, Misako Higashida-Konishi, Keisuke Izumi, Satoshi Hama, Tatsuhiro Oshige, Hisaji Oshima, Yutaka Okano
SCIENTIFIC REPORTS (2022)
Metastatic tumor antigen 1 contributes to hepatocarcinogenesis posttranscriptionally through RNA-binding function
Yung-Tsung Li, Chun-Jen Liu, Jia-Horng Kao, Li-Feng Lin, Hui-Chu Tu, Chih-Chiang Wang, Po-Hsi Huang, Huei-Ru Cheng, Pei-Jer Chen, Ding-Shinn Chen, Hui-Lin Wu
HEPATOLOGY (2023)
Response to Singh et al.
Tai-Chung Tseng, Tetsuya Hosaka, Jia-Horng Kao
AMERICAN JOURNAL OF GASTROENTEROLOGY (2023)
Incidence of Hepatic Decompensation After Nucleos(t)ide Analog Withdrawal: Results From a Large, International, Multiethnic Cohort of Patients With Chronic Hepatitis B (RETRACT-B Study)
Grishma Hirode, Bettina E. Hansen, Chien-Hung Chen, Tung-Hung Su, Grace Wong, Wai-Kay Seto, Stijn Van Hees, Margarita Papatheodoridi, Sylvia M. Brakenhoff, Sabela Lens, Hannah S. J. Choi, Rong-Nan Chien, Jordan J. Feld, Xavier Forns, Milan J. Sonneveld, George V. Papatheodoridis, Thomas Vanwolleghem, Man-Fung Yuen, Henry L. Y. Chan, Jia-Horng Kao, Yao-Chun Hsu, Markus Cornberg, Wen-Juei Jeng, Harry L. A. Janssen
AMERICAN JOURNAL OF GASTROENTEROLOGY (2023)
Optimizing survival benefit by surgical resection by the seven-eleven criteria in Barcelona clinic liver cancer stage A/B hepatocellular carcinoma beyond the Milan criteria
Chian-Tzu Huang, Yu-Long Chu, Tung-Hung Su, Shang-Chin Huang, Tai-Chung Tseng, Shih-Jer Hsu, Sih-Han Liao, Chun-Ming Hong, Chen-Hua Liu, Hung-Chih Yang, Chun-Jen Liu, Pei-Jer Chen, Jia-Horng Kao
LIVER CANCER (2023)
Darolutamide for non-metastatic castration- resistant prostate cancer
Jia-Horng Kao
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2023)
The Highlights
Jia-Horng Kao
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2023)
Pre-operative gamma-glutamyl transferase levels predict outcomes in hepatitis B- related hepatocellular carcinoma after curative resection
Tung-Hung Su, Shang-Chin Huang, Chi-Ling Chen, Shih-Jer Hsu, Sih-Han Liao, Chun-Ming Hong, Tai-Chung Tseng, Chen-Hua Liu, Hung-Chih Yang, Yao-Ming Wu, Chun-Jen Liu, Pei-Jer Chen, Jia-Horng Kao
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2023)
Development of hepatocellular carcinoma in treat- ed and untreated patients with chronic hepatitis B virus infection
Chih-Lin Lin, Jia-Horng Kao
CLINICAL AND MOLECULAR HEPATOLOGY (2023)
Impact of HBV infection on clinical outcomes in patients with metabolic dysfunction-associated fatty liver disease
Yu-Ming Cheng, Tsung-Han Hsieh, Chia-Chi Wang, Jia-Horng Kao
JHEP REPORTS (2023)
Tenofovir alafenamide and tenofovir disoproxil fumarate reduce incidence of hepatocellular carcinoma in patients with chronic hepatitis B
Young-Suk Lim, Henry L. Y. Chan, Sang Hoon Ahn, Wai Kay Seto, Qin Ning, Kosh Agarwal, Harry L. A. Janssen, Calvin Q. Pan, Wan Long Chuang, Namiki Izumi, Scott Fung, Maurizia Shalimar, Maurizia Brunetto, Aric Josun Hui, Ting-Tsung Chang, Seng Gee Lim, Frida Abramov, John F. Flaherty, Hongyuan Wang, Leland J. Yee, Jia-Horng Kao, Edward Gane, Jinlin Hou, Maria Buti
JHEP REPORTS (2023)
Impact of HBV infection on clinical outcomes in patients with metabolic dysfunction-associated fatty liver disease (vol 5 ,100836 , 2023)
Yu-Ming Cheng, Tsung-Han Hsieh, Chia-Chi Wang, Jia-Horng Kao
JHEP REPORTS (2023)
Predictors of severe flares after nucleos (t)ide analogue cessation-results of a global cohort study (RETRACT-B study)
Edo Dongelmans, Grishma Hirode, Bettina Hansen, Chien-Hung Chen, Tung-Hung Su, Wai-Kay Seto, Arno Furquim d'Almeida, Stijn Van Hees, Margarita Papatheodoridi, Sabela Lens, Grace Wong, Sylvia Brakenhoff, Rong-Nan Chien, Jordan J. Feld, Henry Ly Chan, Xavier Forns, George Papatheodoridis, Thomas Vanwolleghem, Man-Fung Yuen, Yao-Chun (Holden) Hsu, Jia-Horng Kao, Markus Cornberg, Milan Sonneveld, Rachel Wen-Juei Jeng, Harry L. A. Janssen
JOURNAL OF HEPATOLOGY (2023)
Utility of partial cure as an end point after nucleos (t)ide analogue withdrawal among chronic hepatitis B patients (RETRACT-B study)
Grishma Hirode, Bettina Hansen, Chien-Hung Chen, Tung-Hung Su, Grace Wong, Wai-Kay Seto, Arno Furquim d'Almeida, Margarita Papatheodoridi, Sylvia Brakenhoff, Sabela Lens, Hannah S. J. Choi, Stijn Van Hees, Rong-Nan Chien, Jordan J. Feld, Xavier Forns, Milan Sonneveld, George Papatheodoridis, Thomas Vanwolleghem, Man-Fung Yuen, Henry L. Y. Chan, Jia-Horng Kao, Yao-Chun (Holden) Hsu, Markus Cornberg, Rachel Wen-Juei Jeng, Harry L. A. Janssen
JOURNAL OF HEPATOLOGY (2023)
The impact of HCV cure on glycemic indices in patients using glecaprevir/pibrentasvir from nationwide Taiwan HCV registry
Chung-Feng Huang, Hsing-Tao Kuo, Te-Sheng Chang, Ching-Chu Lo, Chao-Hung Hung, Chien-Wei Huang, Lee-Won Chong, Pin-Nan Cheng, Ming-Lun Yeh, Cheng-Yuan Peng, Chien-Yu Cheng, Jee-Fu Huang, Ming-Jong Bair, Chih-Lang Lin, Chi-Chieh Yang, Sih-Ren Wang, Tsai-Yuan Hsieh, Tzong-Hsi Lee, Pei-Lun Lee, Wen-Chih Wu, Chih-Lin Lin, Wei-Wen Su, Shengshun Yang, Chia-Chi Wang, Jui-Ting Hu, Lien-Juei Mou, Chun-Ting Chen, Yi-Hsiang Huang, Chun-Chao Chang, Jia-Sheng Huang, Guei-Ying Chen, Jian-Neng Gao, Chi-Ming Tai, Chun-Jen Liu, Mei-Hsuan Lee, Pei-Chien Tsai, Chia-Yen Dai, Jia-Horng Kao, Han-Chieh Lin, Wan-Long Chuang, Chiyi Chen, Kuo-Chih Tseng, Ming-Lung Yu
JOURNAL OF HEPATOLOGY (2023)
Sofosbuvir/velpatasvir or glecaprevir/pibrentasvir for treating patients with hepatitis C virus reinfection following direct-acting antiviral-induced sustained virologic response
Chen-Hua Liu, Chun-Jen Liu, Tung-Hung Su, Tai-Chung Tseng, Pei-Jer Chen, Jia-Horng Kao
ADVANCES IN DIGESTIVE MEDICINE (2023)